Molecular pathology of gastroenterological cancer : application to clinical practice
著者
書誌事項
Molecular pathology of gastroenterological cancer : application to clinical practice
Springer, c1997
- : alk. paper
大学図書館所蔵 全10件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and indexes
内容説明・目次
内容説明
Twenty years have passed since I became a professor in the First Department of Pathology, Hiroshima University School of Medicine. It is my great pleas ure that Molecular Pathology o[ Gastroenterological Cancer-Application to Clinical Practice has been published by Springer-Verlag Tokyo to commemo rate the 20th anniversary of my professorship. Seeing the academic achievements of our department during these 20 years, I am confident that we could establish a department of oncology to research the pathogenesis of human cancer through systemic application of a variety of molecular techniques. We have demonstrated that the develop me nt and progression of esophageal, gastric, and colon cancer require mul tiple alterations affecting DNA mismatch repair genes, oncogenes, and tumorsuppressor genes, and that common and uncommon genetic changes exist for esophageal, gastric, and colorectal carcinomas. In addition to these genetic changes, the majority of gastrointestinal cancers express telomerase activity, with overexpression of telomerase RNA, indicating a powerful addi tional tool for early detection of gastrointestinal cancer. By transferring these basic observations to the clinic, we now are able to make accurate cancer diagnoses, thus determing the grade of malignancy and patient prognosis. We also can identify patients at high risk for developing cancer and create new therapeutic approaches. In fact, we have routinely implemented a new molecular diagnosis strategy at the Hiroshima City Medi cal Association Clinical Laboratory since August 1993.
目次
Experimental Stomach Carcinogenesis.- Multistep Carcinogenesis of Esophageal Carcinoma.- Oxidative Damage During the Gastric Precancerous Process.- Multiple Genetic Alterations and Abnormal Growth Factor Network in Human Esophageal Carcinomas.- Genetic Alterations in the Precursors of Gastric Cancer.- Molecular Bases of Human Stomach Carcinogenesis.- Galectins in Gastric and Colorectal Cancers: Implications for Tumor Progression and Metastasis.- Stomach Cancer and Apoptosis: A Review.- Pathogenesis of Serrated Adenoma of the Colorectum: Implication for Malignant Progression.- Carcinoma Cells at Deeply Infiltrated Sites: Role in Development of Metastases in Patients with Advanced Colorectal Adenocarcinomas.- Glycoprotein Histochemistry and the Histogenesis of Colorectal Cancer.- Critical Determinants of Human Colon Cancer Metastasis.- Abnormal CD44 Gene Expression in Neoplasia: Biological and Clinical Implications.- Molecular Diagnosis of Gastrointestinal Cancer.- Interactive Effects of p53 Tumor Suppressor Gene and Hepatitis B Virus in Hepatocellular Carcinogenesis.- Molecular Genetics of Hepatocellular Carcinoma.- Telomeres and Telomerase in Gastrointestinal Cancers.- Contributor Index.
「Nielsen BookData」 より